SEQUANA THERAPEUTICS
Sequana Therapeutics is a therapeutics company that develops proprietary gene therapy products. Sequana's products are developed using gene discovery technology, enabling medical researchers to facilitate relatively rapid isolation and characterization of disease genes.
SEQUANA THERAPEUTICS
Industry:
Biotechnology Medical Therapeutics
Founded:
1993-01-01
Address:
San Diego, California, United States
Country:
United States
Status:
Active
Similar Organizations
ARase Therapeutics
Arase Therapeutics is a science-focused oncology company developing therapies that modulate cancer-relevant cell signaling pathways.
Ceptaris Therapeutics
Ceptaris Therapeutics is a pharmaceutical company developing therapeutics for symptoms of early-stage mycosis fungoides.
Seed Therapeutics
Seed Therapeutics is a biotech company that focuses on harnessing and engineering molecules.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Founder
More informations about "Sequana Therapeutics"
Sequana Therapeutics 2025 Company Profile: Valuation, Investors ...
Sequana Therapeutics General Information Description. Operator of a therapeutics company intended to develop proprietary gene therapy products. The company's products are …See details»
Sequana Therapeutics, Inc.
Sequana Therapeutics is founded in San Diego, CA by Jay B. Lichter Ph.D. and Kevin Kinsella of Avalon Ventures. The company focuses on using gene discovery technology to determine …See details»
Sequana Therapeutics: Revenue, Worth, Valuation & Competitors …
About Sequana Therapeutics. Sequana Therapeutics is a Biotech related company based in Alameda with an estimated revenue of $31.2M, and 201 employees. It has 10 competitors …See details»
Sequana Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Sequana Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 2 news, and 20 literature.See details»
Sequana Therapeutics - Crunchbase
Sequana Therapeutics is a therapeutics company that develops proprietary gene therapy products.See details»
Sequana Therapeutics - Avalon Ventures
Sequana Therapeutics was one of the first genomics companies and it was founded by Avalon. Although Avalon had intensely studied the area for a half decade prior, the Firm waited to see …See details»
BioPharmaLink profile of SEQUANA THERAPEUTICS, INC., United …
Sequana Therapeutics, Inc. (Nasdaq: SQNA) is a leading genomics company that uses industrial-scale gene finding technologies, advanced biology and bioinformatics to uncover the genetic …See details»
Sequana Therapeutics, Inc. (Sequana Therapeutics, Inc.) - 药物管 …
项与 Sequana Therapeutics, Inc. 相关的文献（医药） 2011-12-01 · Pharmacogenetics and genomics 4区 · 医学 Predicting cirrhosis and clinical outcomes in patients with advanced …See details»
Axys Pharmaceuticals - Funding, Financials, Valuation & Investors
Their most recent acquisition was Sequana Therapeutics on Nov 3, 1997. ... Which types of acquisition does this organization make most frequently? Show . Acquiree Name . Announced …See details»
Sequana Therapeutics - Products, Competitors, Financials, …
Arris to Acquire Sequana for $166 Million - latimes. Jul 24, 2017. Arris to Acquire Sequana for $166 Million Arris Pharmaceuticals Corp., a South San Francisco-based drug research and …See details»
Sequana shares surge after FDA approval for alfapump - Yahoo …
Dec 23, 2024 Sequana’s other lead candidate is a sodium-free dextrose/icodextrin solution for clearing sodium in patients with heart failure. The company has released positive results …See details»
After Shareholder Vote, Arris s Acquisition of Sequana …
Dec 21, 1998 SOUTH SAN FRANCISCO, Calif.--After shareholders of Sequana Therapeutics voted overwhelmingly in favor of the move earlier this month, Arris Pharma ceutical here has …See details»
Sequana Therapeutics, Arris To Merge; Deal Valued At $166M
Nov 4, 1997 In a move that may signal consolidation of genomics and combinatorial chemistry companies, combining technologies that can translate disease gene discovery into small …See details»
Arris Acquires Sequana; Next Year Firms Will Merge into AxyS ...
Dec 21, 1998 SOUTH SAN FRANCISCO, Calif.--Following several months of talks, Arris Pharmaceutical here has agreed to buy La Jolla, Calif.-based Sequana Therapeutics for $166 …See details»
Sequana Medical announces 2024 Full Year Results and 2025 …
Ghent, Belgium – 18 March 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana Medical“), a pioneer in the treatment of fluid overload in liver disease, …See details»
HealthTech startup Sequana Medical secures €24 million to fuel US ...
Mar 18, 2025 Founded in 2006, Sequana Medical has developed the alfapump, an implantable pump system designed to eliminate the need for repeated therapeutic paracentesis in liver …See details»
Sequana Medical - Crunchbase Company Profile & Funding
Sequana Medical is a Swiss medical device company providing implantable pump systems to manage fluid balance within the body. This system is designed to move excess fluid to the …See details»
Sequana Medical announces H1 2024 results and provides …
Ghent, Belgium – 30 September 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana Medical“), a pioneer in the treatment of fluid overload in liver disease, …See details»
Sequana 2025 Company Profile: Valuation, Funding & Investors
Sequana was founded in 1847. Where is Sequana headquartered? Sequana is headquartered in Boulogne-Billancourt, France. What is the size of Sequana? Sequana has 8,198 total …See details»
BeiGene to Present New Data from SEQUOIA Study Evaluating …
Jun 14, 2024 SAN MATEO, Calif.--(BUSINESS WIRE)--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, announced the presentation of new data …See details»